Lipocine Inc (LPCN) stock is up 12.50% over the past week and gets a Bullish rating from InvestorsObserver's Sentiment Indicator.
What is Stock Sentiment?
In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company.
Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down.
InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend.
Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.
What's Happening With LPCN Stock Today?
Lipocine Inc (LPCN) stock is trading at $1.44 as of 11:54 AM on Tuesday, Sep 15, a gain of $0.11, or 8.27% from the previous closing price of $1.33. The stock has traded between $1.35 and $1.49 so far today. Volume today is light. So far 1,760,122 shares have traded compared to average volume of 6,213,180 shares.
To see InvestorsObserver's Sentiment Score for Lipocine Inc click here.
More About Lipocine Inc
Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO, is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148 and LPCN 1107.
Click Here to get the full Stock Score Report on Lipocine Inc (LPCN) Stock.